Research identifies increased risks associated... - CLL Support
Research identifies increased risks associated with SARS-CoV-2 infection beyond the initial COVID-19 illness
You need to be a member of this community to see this post.
Read more about...
2 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Dr. John Byrd: Monitoring Vaccination Effectiveness for Preventing SARS-CoV-2 Infection & COVID-19 Syndrome in CLL
CLL Society's new Opinion Page: Dr. John Byrd on Monitoring Vaccination Effectiveness for...
Important SARS-CoV-2 and Covid-19 information for Chronic Lymphocytic Leukaemia/CLL patients
This post, prepared in collaboration with @[52122] , draws together some earlier posts...
Research shows blood cancer patients generate strong T cell immunity after SARS-CoV-2 vaccination
Today, the Doherty Institute in Melbourne, Australia, released a statement about a research study...
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T
We evaluated 254 COVID-19 patients longitudinally from early infection and for eight months...
LLS Covid-19 Vaccine Trial: Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies
Posted July 29, 2021 by Dr. Brian Koffman...
Related Posts
Vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infect
Living in the USA with CLL and want to know where to sign up for your COVID-19 Vaccination? A State-by-State List
Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab
happened to see this article In a news feed regarding B and T cells, Covid and antibodies…- The Benefits of Exercise with CLL and COVID-19
